A Study to Evaluate Safety and Efficacy of BOTOX in Adults With Moderate COPD

NCT06003049 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD

Interventions

DRUG: OnabotulinumtoxinA
OTHER: Placebo

Sponsor

RMW Testing